Goldsite Team at WHX Labs Kuala Lumpur Grand Opening Day

At one of Southeast Asia’s largest medical laboratory exhibitions, the Goldsite team showcased its flagship products—HbA1c POCT Analyzer, HPLC solutions, GPP-100 Specific Protein Analyzer, and the newly launched GH-3100 Hematology Analyzer—at booth J55. This  not only highlights Goldsite’s innovative technology but also underscores the critical importance of introducing advanced diagnostic tools to the densely populated and medically underserved markets of South and Southeast Asia, where healthcare demand is surging but the medical device industry lags behind.

The Rising Medical Demand in South and Southeast Asia

South Asia, home to over 1.9 billion people, is one of the most densely populated regions in the world. Countries like India, Pakistan, and Bangladesh face a growing burden of chronic diseases such as diabetes, cardiovascular conditions, and anemia, alongside persistent infectious diseases like tuberculosis and dengue. The International Diabetes Federation reported that South Asia had 153 million adults with diabetes in 2021, a figure projected to rise sharply by 2030. Yet, the region’s medical device industry remains underdeveloped, with high-end equipment heavily reliant on imports. This gap presents immense opportunities for companies like Goldsite Diagnostics to address unmet needs with innovative, scalable solutions.India, with its massive population and expanding middle class, is a key market but faces challenges like limited healthcare infrastructure in rural areas. Pakistan and Bangladesh, similarly, struggle with access to advanced diagnostics, making point-of-care testing (POCT) and high-throughput systems critical for improving healthcare delivery. The reliance on imported high-end equipment underscores the need for reliable, cost-effective solutions tailored to the region’s diverse needs.

Addresses the unique healthcare and market dynamics of South and Southeast Asia

HbA1c POCT Analyzer: Accessible Diabetes Care

The HbA1c POCT Analyzer is a vital tool for managing the diabetes epidemic in both regions. With rapid results from a small blood sample, it’s ideal for rural clinics in India and Bangladesh or busy urban centers in Malaysia and Thailand. Its boronate affinity chromatography ensures accuracy despite hemoglobin variants like HbE, common in South and Southeast Asian populations. In areas with limited lab access, this device enables immediate clinical decisions, reducing patient wait times and improving treatment adherence—a critical factor given that 50% of diabetes patients in South Asia remain undiagnosed, according to WHO data.

HPLC Solutions: Precision for High-Volume Labs

The GSH-60 HPLC system offers unmatched precision for HbA1c testing, essential for regions with high prevalence of diabetes. In urban hubs like Mumbai, Karachi, Jakarta, or Singapore, where laboratories handle large patient volumes, the system’s automation and 60-second test turnaround time enhance efficiency. By addressing the need for reliable diagnostics in high-throughput settings, HPLC solutions cater to the growing demand for precision medicine in both regions’ major cities.

GPP-100 Specific Protein Analyzer: Versatile Diagnostics

The GPP-100’s ability to measure biomarkers like C-reactive protein (CRP) supports the diagnosis of both infectious and chronic conditions, cardiovascular diseases in Pakistan. Its compact, automated design suits diverse settings, from small clinics in rural Bangladesh to advanced hospitals in Singapore. This versatility aligns with the region’s need for scalable, multi-purpose diagnostic tools.

GH-3100 Hematology Analyzer: Compact and Efficient

The GH-3100, 3 Part hematology analyzer, is ideal for addressing anemia prevalent in South Asia. Its compact design and integration with electronic medical records make it a fit for both resource-constrained clinics in Pakistan and high-demand facilities in Malaysia, supporting the region’s need for efficient diagnosticsExplore Goldsite’s Innovations at Medlab

❏ About Goldsite

Established in 1999 and headquartered in Shenzhen, China, Goldsite Diagnostics Inc. is a leading manufacturer of in vitro diagnostic (IVD) products. We are dedicated to the research, development, manufacturing, sales, and service of clinical testing instruments and reagents. Our product range includes specific proteins, HbA1c, hematology, chemistry, immunofluorescence, and chemiluminescence assays. Known for high manufacturing standards, our products are widely recognized and have successfully entered over 100 countries worldwide.